AOH1996 for the Treatment of Refractory Solid Tumors — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

AOH1996 for the Treatment of Refractory Solid Tumors — Stella

Recruiting

Back to Refractory Malignant Solid Neoplasm trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(2 sites)

United States

Honor Health Research and Innovation Institute, Scottsdale, Arizona

City of Hope Medical Center, Duarte, California

Key details

Phase

Early testing

Sponsor

City of Hope Medical Center

Collaborators

National Cancer Institute (NCI)

Enrollment target

~92 participants

Started

August 2022

Primary completion

September 2029

Age range

18 Years and older

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov